These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9332178)

  • 21. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fosfomycin--a new antibiotic in rhinootolaryngology].
    Stammberger H
    HNO; 1983 Dec; 31(12):436-9. PubMed ID: 6662741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent.
    Radhakrishnan V; Ganguly K; Ganguly M; Dastidar SG; Chakrabarty AN
    Indian J Exp Biol; 1999 Jul; 37(7):671-5. PubMed ID: 10522156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ; Matesanz David M; Barberán J
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
    Niebuhr M; Mai U; Kapp A; Werfel T
    Exp Dermatol; 2008 Nov; 17(11):953-7. PubMed ID: 18557929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum beta-lactamases: will they be the new 'methicillin-resistant Staphylococcus aureus'?
    Hicks JA; Harris MR; Keoghane SR
    BJU Int; 2008 Jan; 101(2):151-2. PubMed ID: 17760887
    [No Abstract]   [Full Text] [Related]  

  • 31. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
    Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of fosfomycin].
    Tauchnitz C; Ezold R; Gonschorek J
    Z Gesamte Inn Med; 1982 May; 37(9):253-9. PubMed ID: 7048772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fosfomycin therapy of experimental infections in mice.
    Schindler J; Langsádl L
    Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):136-9. PubMed ID: 375622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activity of fosfomycin].
    Ceruti T; Biazzi E; D'Avossa I; Pennacchio A; Santini F
    Arch Sci Med (Torino); 1980; 137(2):221-4. PubMed ID: 7224844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prerequisites for enhancement of the efficacy of fosfomycin by glucose-6-phosphate in treatment of experimentally infected animals (author's transl)].
    Hirschl A; Stanek G; Rotter M; Holzmann A; Frisch-Niggemeyer W; Laber G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):529-39. PubMed ID: 7036592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fosfomycin, lysine-fosfomycin, arginine-fosfomycin: antibacterial activity in vitro].
    Angeretti A; Martinetto P; Valtz A
    G Batteriol Virol Immunol; 1980; 73(7-12):272-80. PubMed ID: 6796449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of an antibioprophylaxis with pefloxacin and fosfomycin in cardiac surgery in patients with beta-lactam hypersensitivity].
    Vergnaud M; Morel C; Malbruny B; Lebreton P; Zerr C; Nigam M
    Pathol Biol (Paris); 1989 May; 37(5):491-5. PubMed ID: 2780106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.